AdventHealth Celebration
Kissimmee, Florida, 34747, United States
Location contact
Bridget Miller, MS, MPH
CONTACT
Michael Seidman, MD, FACS
PRINCIPAL_INVESTIGATOR
Petronio Martins, MHA
CONTACT
NCT Number: NCT07081542
This research study is evaluating two different methods of cochlear implant (CI) insertion - robotic-assisted insertion and manual insertion - to better understand how they affect hearing outcomes. Participants in this study will be randomly assigned to receive their cochlear implant using one of these two techniques. Both methods are performed in a standard operating room by qualified surgeons, and both are considered safe and approved for use.
The main goal is to compare how well participants hear one year after surgery based on the insertion method used. The study will also look at things like surgical time, inner ear health, and how the hearing nerve responds. All participants will receive the same type of cochlear implant device and follow-up care.
This study may help guide future surgical techniques and improve outcomes for individuals receiving cochlear implants.
Trial opening soon.
Get Notified18 year–80 year
All sexes
Interventional
Not applicable
Kissimmee, Florida, 34747, United States
Bridget Miller, MS, MPH
CONTACT
Michael Seidman, MD, FACS
PRINCIPAL_INVESTIGATOR
Petronio Martins, MHA
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The IotaSoft robotic insertion device is an FDA-approved tool designed to provide precise and controlled insertion of the cochlear implant electrode array to minimize trauma during implantation.
Standard surgical technique for manually inserting the cochlear implant electrode array. This method reflects the current standard of care without the assistance of robotic tools.
Time frame: Baseline (pre-op) to 12 months post-activation
Change in unaided pure tone thresholds at 125, 250, and 500 Hz from baseline to 12 months post-activation. The average of these frequencies will be computed for each participant.
Time frame: 3, 6, and 12 months post-activation
Participants' ability to recognize individual spoken words will be assessed using the Consonant-Nucleus-Consonant (CNC) word test in both quiet and noise conditions. Outcome is based on the percent of key words correctly repeated.
Time frame: 3, 6, and 12 months post-activation
Participants' ability to recognize spoken sentences will be assessed using the AzBio sentence test in quiet and noise. Outcome is based on the percent of key words correctly repeated in standardized sentence lists.
Time frame: Baseline to 12 months post-activation
Subjects will be categorized based on change in LFPTA into:
Time frame: CI activation (6-8 weeks post-op)
To assess device function and consistency over time by measuring electrical impedance (in kilo-ohms, kΩ) of cochlear implant electrodes following either robotic or manual insertion. Impedance will be recorded at activation. Lower and more stable impedance values are expected to indicate better electrode-tissue interface and improved device function. The hypothesis is that robotic cochlear implantation will result in lower and more consistent impedance values compared to manual insertion.
Contact information is provided by the study sponsor or research team.
Bridget Clinical Research Operations Manager, MS, MPH
CONTACT
Petronio Senior Clinical Research Operations Manager, MHA
CONTACT
AdventHealth
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00023049
Deafness, Ear Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00023036
Cytomegalovirus Infection, Cytomegalovirus Infections
Bethesda, Maryland, United States
View Trial DetailsNCT06936449
Bilateral Hearing Loss, Ear Diseases
Englewood, Colorado, United States
View Trial DetailsNCT06229717
Children, Only, Dizziness
Herning, Denmark
View Trial Details